Stephen Thomas
Directeur/Bestuurslid bij ELIEM THERAPEUTICS, INC.
Vermogen: 801 123 $ op 31-05-2024
Actieve functies van Stephen Thomas
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ELIEM THERAPEUTICS, INC. | Directeur/Bestuurslid | 27-06-2024 | - |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Oprichter | 07-07-2017 | - |
Loopbaan van Stephen Thomas
Statistieken
Internationaal
| Verenigde Staten | 2 |
| 2 |
Operationeel
| Founder | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Health Technology |
| Eliem Therapeutics, Inc. |
- Beurs
- Insiders
- Stephen Thomas
- Ervaring
